BiomX Inc. (PHGE)

0.3686 -0.0314 (-7.85%) At close: 03:52PM EDT

BiomX Inc.

22 Einstein Street
Floor 4
Ness Ziona 7414003
Israel
972 7 2394 2377
https://www.biomx.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 58

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jonathan Eitan Solomon MBA	CEO & Director	714.37k	N/A	1977
Dr. Merav Bassan Ph.D.	Chief Development Officer	437.71k	N/A	1966
Ms. Marina Wolfson CPA	CFO & Secretary (Leave of Absence)	337.51k	N/A	1984
Prof. Rotem Sorek Ph.D.	Scientific Founder	N/A	N/A	N/A
Dr. Eran Elinav M.D., Ph.D.	Scientific Founder	N/A	N/A	N/A
Dr. Timothy K. Lu M.D., Ph.D.	Scientific Founder	N/A	N/A	1981
Mr. Avraham Gabay	Interim Chief Financial Officer	N/A	N/A	1986
Ms. Inbal Benjamini-Elran	C.H.R.O	N/A	N/A	N/A
Mr. Assaf Oron	Chief Business Officer	352.04k	N/A	1974

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Corporate governance

BiomX Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.